AQR Arbitrage’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

AQR Arbitrage’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-45,385	Closed	-$2.73M	–	1431
2021 Q1	$2.73M	Buy	+45,385	New	+$1.64M	0.1%	184

AQR Arbitrage's PAND Position: Q2 2021 in Review

AQR Arbitrage sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 45,385 shares — an estimated $2.73M sold.

AQR Arbitrage first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $2.73M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

AQR Arbitrage reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
AQR Arbitrage sold 45,385 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $2.73M.
AQR Arbitrage first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
AQR Arbitrage's Pandion Therapeutics Inc. Common Stock position peaked at $2.73M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on AQR Arbitrage's 13F filing for Q2 2021, filed 16 Aug 2021.